These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1792648)

  • 1. [International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group].
    Royer RJ; Benichou C
    Therapie; 1991; 46(3):173-8. PubMed ID: 1792648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International reporting on adverse drug reactions: the CIOMS project. CIOMS ADR Working Group.
    Faich GA; Castle W; Bankowski Z
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):133-8. PubMed ID: 2338366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.
    Benichou C; Solal Celigny P
    Nouv Rev Fr Hematol (1978); 1991; 33(3):257-62. PubMed ID: 1956763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing requirements for the use of terms for reporting adverse drug reactions (ADR). Consultant, Council for International Organizations of Medical Sciences (CIOMS), World Health Organization.
    Mater Med Pol; 1993; 25(1):45-6. PubMed ID: 8412342
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of standardized screening procedures to identify adverse drug reactions.
    Koch KE
    Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The international system of drug control].
    Barbadoro E
    Boll Chim Farm; 1990 Mar; 129(3):140-3. PubMed ID: 2245002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food and Drug Administration monitoring of adverse drug reactions.
    Sills JM; Tanner LA; Milstien JB
    Am J Hosp Pharm; 1986 Nov; 43(11):2764-70. PubMed ID: 3799612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National adverse drug reaction reporting. 1984-1989.
    Faich GA
    Arch Intern Med; 1991 Aug; 151(8):1645-7. PubMed ID: 1872669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. System for voluntary reporting of adverse drug reactions in a university hospital.
    Vorce-West TE; Barstow L; Butcher B
    Am J Hosp Pharm; 1989 Nov; 46(11):2300-3. PubMed ID: 2589347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Working toward uniformity in evaluation of ADR-reporting programs.
    Woodson HA
    Am J Hosp Pharm; 1991 Jul; 48(7):1428. PubMed ID: 1882866
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse drug reactions: a review of relevant factors.
    Ajayi FO; Sun H; Perry J
    J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Organization and results of drug vigilance in France].
    Bégaud B; Chaslerie A; Haramburu F
    Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.
    Fed Regist; 1993 Jun; 58(105):31596-614. PubMed ID: 10171452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (X): gastrointestinal system disorders.
    Pharmacoepidemiol Drug Saf; 1998 Jul; 7(4):281-7. PubMed ID: 15073991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XIII): clinical pathology and general disorders.
    Council for International Organization of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 May; 8(3):217-24. PubMed ID: 15073931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia.
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):75-81. PubMed ID: 2026468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XII): collagen disorders and musculo-skeletal disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 Mar; 8(2):141-5. PubMed ID: 15073939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders.
    Bankowski Z
    Pharmacoepidemiol Drug Saf; 1998 Sep; 7(5):351-7. PubMed ID: 15073983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving adverse drug reaction reporting in the community setting.
    McCloskey BA
    Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.